Journal Watch · Journal of Immunology · 2026
Negative regulation of a new collectin-11/calreticulin-mediated NF-κB pathway by miR-194b-3p in antibacterial immunity of Takifugu obscurus.
These results elucidate the immune regulatory function of ToCL-11 and its modulation by TomiR-194b-3p, underscoring their potential as therapeutic targets for enhancing immunity in aquaculture.
TL;DR
These results elucidate the immune regulatory function of ToCL-11 and its modulation by TomiR-194b-3p, underscoring their potential as therapeutic targets for enhancing immunity in aquaculture.
Key findings
- RNAi-mediated knockdown of ToCRT and ToCL-11 suppressed nuclear translocation of nuclear factor-kappa B (ToNF-κB), leading to reduced expression of pro-inflammatory cytokines, including interleukin-1β (ToIL-1β), ToIL-6, ToIL-8, and tumor necrosis factor-α (ToTNF-α), and impaired bacterial clearance.
- Luciferase reporter assays and in vivo studies confirmed that TomiR-194b-3p directly targets ToCL-11 and acts as a negative regulator.
- Overexpression of TomiR-194b-3p downregulated ToCL-11, inhibited ToNF-κB nuclear translocation, and suppressed cytokine expression, whereas its knockdown elicited opposite effects.
- These results elucidate the immune regulatory function of ToCL-11 and its modulation by TomiR-194b-3p, underscoring their potential as therapeutic targets for enhancing immunity in aquaculture.
What they did
Subcellular localization analysis revealed that ToCL-11 is secreted and undergoes pathogen-specific redistribution upon bacterial stimulation. Expression of ToCL-11 was highest in immune tissues (liver, intestine, and kidney) and was upregulated following bacterial challenge. Recombinant ToCL-11 (rToCL-11) and its CRD (rToCL-11-CRD) exhibited broad-spectrum antibacterial activities, including bacterial binding, agglutination, growth inhibition, and biofilm suppression, with rToCL-11 showing stronger activity. rToCL-11 was also found to interact with recombinant calreticulin (rToCRT) via its collagen domain (rToCL-11-Collagen).
Full abstract (original)
Background: The innate immune system of teleost fish, such as Takifugu obscurus, depends on pattern recognition receptors to detect microbes and mount immune responses. In this study, a new collectin gene was identified in T. obscurus, designated ToCL-11. The full-length cDNA of ToCL-11 encodes a 266-amino acid protein featuring a signal peptide, a collagen-like domain, and a carbohydrate-recognition domain (CRD).
What they did: Subcellular localization analysis revealed that ToCL-11 is secreted and undergoes pathogen-specific redistribution upon bacterial stimulation. Expression of ToCL-11 was highest in immune tissues (liver, intestine, and kidney) and was upregulated following bacterial challenge. Recombinant ToCL-11 (rToCL-11) and its CRD (rToCL-11-CRD) exhibited broad-spectrum antibacterial activities, including bacterial binding, agglutination, growth inhibition, and biofilm suppression, with rToCL-11 showing stronger activity. rToCL-11 was also found to interact with recombinant calreticulin (rToCRT) via its collagen domain (rToCL-11-Collagen).
Results & conclusions: RNAi-mediated knockdown of ToCRT and ToCL-11 suppressed nuclear translocation of nuclear factor-kappa B (ToNF-κB), leading to reduced expression of pro-inflammatory cytokines, including interleukin-1β (ToIL-1β), ToIL-6, ToIL-8, and tumor necrosis factor-α (ToTNF-α), and impaired bacterial clearance. Luciferase reporter assays and in vivo studies confirmed that TomiR-194b-3p directly targets ToCL-11 and acts as a negative regulator. Overexpression of TomiR-194b-3p downregulated ToCL-11, inhibited ToNF-κB nuclear translocation, and suppressed cytokine expression, whereas its knockdown elicited opposite effects. These results elucidate the immune regulatory function of ToCL-11 and its modulation by TomiR-194b-3p, underscoring their potential as therapeutic targets for enhancing immunity in aquaculture.
Abstract © the authors / Journal of Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1093/jimmun/vkaf319 · PubMed 41423895.
Why it matters for pharma & biotech
- Relevant to Immunology teams tracking Journal of Immunology for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Journal of Immunology study find?
These results elucidate the immune regulatory function of ToCL-11 and its modulation by TomiR-194b-3p, underscoring their potential as therapeutic targets for enhancing immunity in aquaculture.
What type of study is this?
It is a research study, published in Journal of Immunology in 2026. Subcellular localization analysis revealed that ToCL-11 is secreted and undergoes pathogen-specific redistribution upon bacterial stimulation.
Where can I read the original paper?
The original is at the publisher via DOI 10.1093/jimmun/vkaf319. PubMed ID: 41423895. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/negative-regulation-of-a-new-collectin-11-calreticulin-mediated-nf-b-pat-kaf319/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides